Until recently, our understanding of Parkinson’s disease has been quite limited, which has been apparent in the limited treatment options and management of this debilitating condition.
Tag: Parkinson’s disease
Newly discovered trigger of Parkinson’s upends common beliefs
A new Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease. Degeneration of dopaminergic neurons is widely accepted as the first event that leads to Parkinson’s.
Inhaled beta-2 agonists are not associated with a lower risk of Parkinson’s disease
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
AI study finds that patients with Parkinson’s disease speak differently to healthy patients
Using artificial intelligence (AI) to process natural language, a research group evaluated the characteristics of speech among patients with Parkinson’s disease (PD).
Neuro Annual Report 2023: A Year of Patients, Progress
The Departments of Neurology and Neurosurgery at Cedars-Sinai highlighted progress against Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, brain cancer and stroke in their 2023 Annual Report, which also details advancements in spine surgery.
Parkinson’s medication improved blood pressure in teens with Type 1 diabetes
Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson’s disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.
‘A Silent Killer’ – COVID-19 Shown to Trigger Inflammation in the Brain
Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease.
Ultra-powerful brain scanners offer hope for treating cognitive symptoms in Parkinson’s disease
Ultra-powerful 7T MRI scanners could be used to help identify those patients with Parkinson’s disease and similar conditions most likely to benefit from new treatments for previously-untreatable symptoms, say scientists.
Circuit model may explain how deep brain stimulation treats Parkinson’s disease symptoms
People with Parkinson’s disease and their doctors confront many unknowns, including the answer to exactly how deep brain stimulation (DBS) relieves some of the motor symptoms patients experience.
New Approach Methodologies, Single Cell RNAseq, and More Featured in 2021 Toxicological Sciences
Toxicological Sciences delivers cutting-edge research in toxicology in the areas of clinical and translational toxicology, emerging technologies, and more in the August 2021 issue.
An amyloid link between Parkinson’s disease and melanoma
For nearly 50 years, doctors have recognized that Parkinson’s disease patients have an increased risk of melanoma. Now, scientists report a link between the two diseases in the form of protein aggregates known as amyloids. They will present their results at ACS Spring 2021.
Press and Media Registration is Open for 2021 AAN Annual Meeting
No matter where you are in the world, the 2021 AAN Annual Meeting is one click away. Journalists can now register to attend the 73rd Annual Meeting of the American Academy of Neurology (AAN) being held virtually April 17-22, 2021. The AAN Annual Meeting is the world’s largest gathering of neurologists who come together to share the latest advances in neurologic research.
Advanced MRI Scans May Improve Treatment of Tremor, Parkinson’s Disease
DALLAS – June 14, 2020 – Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests.
University of Kentucky Research Could Help Predict Progression of Parkinson’s Disease
Researchers from the University of Kentucky’s College of Medicine are leading a clinical study that could provide a promising new method for early detection of Parkinson’s disease.
Better Biosensor Technology Created for Stem Cells
A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders. The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons), according to a study in the journal Nano Letters.